IDH1/2 mutations are detected in 13–36% of intrahepatic cholangiocarcinoma and <1% of extrahepatic cholangiocarcinoma, with more women harboring IDH-1 mutations than men [2,28,29]. This evidence concerns the gene IDH1 and intrahepatic cholangiocarcinoma.